The global genotyping market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine and rising prevalence of chronic diseases. The genotyping market is segmented on the basis of type, application, and region. Polymerase Chain Reaction (PCR) accounted for the largest share in the genotyping market in 2018 owing to its high accuracy and low cost-per-sample ratio. PCR was followed by sequencing which accounted for a share of 27% in 2018 due to its high accuracy and low cost per sample ratio. Microarray accounted for a share of 18% in 2018 due to its ability to analyze large number of samples simultaneously with high throughput capacity. Electrophoresis had a share of 12% in 2018 owing to its ability to analyze large number of samples simultaneously with high throughput capacity but it has lower accuracy than other types such as PCR or sequencing which are used extensively in clinical diagnostics applications such as pharmacogenomics or diagnostic research applications such as animal genetics or agricultural biotechnology respectively.
Industry Growth Insights published a new data on “Genotyping Market”. The research report is titled “Genotyping Market research by Types (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI-TOF), By Applications (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), By Players/Companies Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter, Roche, GE Healthcare”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Genotyping Market Research Report
By Type
Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI-TOF
By Application
Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology
By Companies
Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter, Roche, GE Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Genotyping Market Report Segments:
The global Genotyping market is segmented on the basis of:
Types
Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI-TOF
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Affymetrix
- Life Technologies
- Agilent Technologies
- Qiagen
- Sequenom
- Fluidigm
- Beckman Coulter
- Roche
- GE Healthcare
Highlights of The Genotyping Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymerase Chain Reaction
- Sequencing
- Microarray
- Electrophoresis
- MALDI-TOF
- By Application:
- Pharmacogenomics
- Diagnostic Research
- Animal Genetics
- Agricultural Biotechnology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genotyping Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genotyping is the process of determining the genetic makeup of a sample, typically DNA. This information can be used to identify specific traits or patterns in that sample.
Some of the key players operating in the genotyping market are Illumina, Affymetrix, Life Technologies, Agilent Technologies, Qiagen, Sequenom, Fluidigm, Beckman Coulter, Roche, GE Healthcare.
The genotyping market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Genotyping Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Genotyping Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Genotyping Market - Supply Chain
4.5. Global Genotyping Market Forecast
4.5.1. Genotyping Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Genotyping Market Size (000 Units) and Y-o-Y Growth
4.5.3. Genotyping Market Absolute $ Opportunity
5. Global Genotyping Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Genotyping Market Size and Volume Forecast by Type
5.3.1. Polymerase Chain Reaction
5.3.2. Sequencing
5.3.3. Microarray
5.3.4. Electrophoresis
5.3.5. MALDI-TOF
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Genotyping Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Genotyping Market Size and Volume Forecast by Application
6.3.1. Pharmacogenomics
6.3.2. Diagnostic Research
6.3.3. Animal Genetics
6.3.4. Agricultural Biotechnology
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Genotyping Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Genotyping Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Genotyping Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Genotyping Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Genotyping Demand Share Forecast, 2019-2026
9. North America Genotyping Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Genotyping Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Genotyping Market Size and Volume Forecast by Application
9.4.1. Pharmacogenomics
9.4.2. Diagnostic Research
9.4.3. Animal Genetics
9.4.4. Agricultural Biotechnology
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Genotyping Market Size and Volume Forecast by Type
9.7.1. Polymerase Chain Reaction
9.7.2. Sequencing
9.7.3. Microarray
9.7.4. Electrophoresis
9.7.5. MALDI-TOF
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Genotyping Demand Share Forecast, 2019-2026
10. Latin America Genotyping Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Genotyping Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Genotyping Market Size and Volume Forecast by Application
10.4.1. Pharmacogenomics
10.4.2. Diagnostic Research
10.4.3. Animal Genetics
10.4.4. Agricultural Biotechnology
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Genotyping Market Size and Volume Forecast by Type
10.7.1. Polymerase Chain Reaction
10.7.2. Sequencing
10.7.3. Microarray
10.7.4. Electrophoresis
10.7.5. MALDI-TOF
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Genotyping Demand Share Forecast, 2019-2026
11. Europe Genotyping Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Genotyping Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Genotyping Market Size and Volume Forecast by Application
11.4.1. Pharmacogenomics
11.4.2. Diagnostic Research
11.4.3. Animal Genetics
11.4.4. Agricultural Biotechnology
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Genotyping Market Size and Volume Forecast by Type
11.7.1. Polymerase Chain Reaction
11.7.2. Sequencing
11.7.3. Microarray
11.7.4. Electrophoresis
11.7.5. MALDI-TOF
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Genotyping Demand Share, 2019-2026
12. Asia Pacific Genotyping Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Genotyping Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Genotyping Market Size and Volume Forecast by Application
12.4.1. Pharmacogenomics
12.4.2. Diagnostic Research
12.4.3. Animal Genetics
12.4.4. Agricultural Biotechnology
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Genotyping Market Size and Volume Forecast by Type
12.7.1. Polymerase Chain Reaction
12.7.2. Sequencing
12.7.3. Microarray
12.7.4. Electrophoresis
12.7.5. MALDI-TOF
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Genotyping Demand Share, 2019-2026
13. Middle East & Africa Genotyping Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Genotyping Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Genotyping Market Size and Volume Forecast by Application
13.4.1. Pharmacogenomics
13.4.2. Diagnostic Research
13.4.3. Animal Genetics
13.4.4. Agricultural Biotechnology
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Genotyping Market Size and Volume Forecast by Type
13.7.1. Polymerase Chain Reaction
13.7.2. Sequencing
13.7.3. Microarray
13.7.4. Electrophoresis
13.7.5. MALDI-TOF
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Genotyping Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Genotyping Market: Market Share Analysis
14.2. Genotyping Distributors and Customers
14.3. Genotyping Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Illumina
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Affymetrix
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Life Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Agilent Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Qiagen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sequenom
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fluidigm
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Beckman Coulter
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Roche
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. GE Healthcare
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
